By Mill Chart
Last update: Apr 26, 2024
Which stocks are moving before the opening bell on Friday?
Ticker | Change | Comment |
---|---|---|
PEGY | 56.65% | PINEAPPLE ENERGY INC's (NASDAQ:PEGY) shares rose 56.65% to $0.08. In the last 3 months the stock lost 89.82%. |
FRGT | 34.62% | FREIGHT TECHNOLOGIES INC (NASDAQ:FRGT) experienced an impressive 34.62% increase in share price, reaching $1.23 during the pre-market session on Friday. The stock is trading 28.62% lower than a month ago. |
KTRA | 27.85% | During Friday's pre-market session, KINTARA THERAPEUTICS INC (NASDAQ:KTRA) experienced a 27.85% increase, with the stock price reaching $0.2. Building on yesterday's 15.08% gain, NASDAQ:KTRA shows continued strength in today's pre-market session. |
SNAP | 23.07% | SNAP INC - A's (NYSE:SNAP) stock price increased by 23.07% to $14.03. A press release (Snap Inc. Announces First Quarter 2024 Financial Results) was released yesterday. |
SLCA | 20.21% | US SILICA HOLDINGS INC (NYSE:SLCA) recorded a 20.21% increase in share price during the pre-market session, reaching $15.7 on Friday. The company's earnings where released Yesterday. |
ELWS | 18.71% | EARLYWORKS CO LTD-ADR's (NASDAQ:ELWS) stock price is advancing with 18.71% to a price of $0.87. The positive momentum from yesterday's 18.98% gain carries forward into today's pre-market session, with an additional 18.71% increase. |
BOF | 17.86% | BRANCHOUT FOOD INC/OR's (NASDAQ:BOF) shares rose 17.86% to $2.31. Shareholders saw the stock price going 70.43% higher in the past 3 months. |
SAVAW | 16.09% | During Friday's pre-market session, CASSAVA SCIENCES INC-28 (NASDAQ:SAVAW) exhibited strong growth, with the stock price climbing 16.09% to $0.36. Following yesterday's 40.89% increase, NASDAQ:SAVAW demonstrates further positive momentum in today's pre-market session with a 16.09% gain. |
VVOS | 14.64% | VIVOS THERAPEUTICS INC's (NASDAQ:VVOS) stock price increased by 14.64% to $2.82. In the last month the stock lost 47.1%. |
WKSP | 14.63% | WORKSPORT LTD's (NASDAQ:WKSP) shares surged 14.63% to reach $0.47 during the pre-market session on Friday. Yesterday the company had a press release: Worksport Signals Undervalued Status, Eyes Major 2024 Growth. |
Our premarket gainers page will show you the full list.
Ticker | Change | Comment |
---|---|---|
DCFC | -62.91% | TRITIUM DCFC LTD's (NASDAQ:DCFC) shares fell 62.91% to $1.35 during Friday's pre-market session. Shareholders saw the stock price going 73.62% lower in the past month. |
VINC | -18.1% | Friday's pre-market session showed a 18.1% decrease in the stock price of VINCERX PHARMA INC (NASDAQ:VINC), reaching $0.73. In the last month the stock lost 85.2%. |
AIRE | -15.11% | REALPHA TECH CORP's (NASDAQ:AIRE) stock price is declining with 15.11% to a price of $1.18. Following yesterday's notable 19.83% increase, NASDAQ:AIRE undergoes a 15.11% decrease in today's pre-market session, suggesting a temporary pullback. Two days ago the company had a press release: reAlpha Tech Corp. Launches Claire, Real Estate’s First AI-powered, Zero-Commission Smart Buyer’s Agent. |
MRIN | -14.83% | Investors observed a 14.83% decline in MARIN SOFTWARE INC's (NASDAQ:MRIN) stock price, which now stands at $2.01 during Friday's pre-market session. In the last month the stock gained 40.48%. |
SAIA | -14.37% | Despite yesterday's decline, SAIA INC (NASDAQ:SAIA) experienced a further 14.37% decrease in share price during Friday's pre-market session, reaching $465.0. yesterday the company released their earnings. Earlier today the company had a press release: Saia Announces Upcoming Retirement of CFO Douglas Col. |
WORX | -14.13% | The stock price of SCWORX CORP (NASDAQ:WORX) is experiencing a decline of 14.13%, reaching $2.37 in today's pre-market session on Friday. After a strong performance yesterday with a 35.96% gain, NASDAQ:WORX shows signs of retracement with a 14.13% decline in today's pre-market session. |
ACON | -13.93% | ACLARION INC's (NASDAQ:ACON) shares fell 13.93% to $0.34 during Friday's pre-market session. Prices are quite volatile now: this is a reversal from yesterday's 36.35% gain. |
NUWE | -13.56% | NUWELLIS INC's (NASDAQ:NUWE) shares experienced a 13.56% decline, falling to $0.25 during Friday's pre-market session. After experiencing a 14.64% increase in yesterday's session, NASDAQ:NUWE is showing a reversal in today's pre-market session with a 13.56% decrease. |
PCSA | -13.17% | The pre-market session on Friday witnessed a 13.17% decrease in PROCESSA PHARMACEUTICALS INC's (NASDAQ:PCSA) shares, with the stock price falling to $2.11. The current market conditions exhibit high volatility as NASDAQ:PCSA retraces its steps after yesterday's 50.0% gain. |
CSSE | -13.08% | Despite yesterday's decline, CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) experienced a further 13.08% decrease in share price during Friday's pre-market session, reaching $0.23. The downward trend from yesterday's -38.87% drop persisted in today's pre-market session, with another decline of 13.08% for NASDAQ:CSSE. |
Our premarket losers page will show you the full list.
VINCERX PHARMA INC
NASDAQ:VINC (5/8/2024, 7:25:26 PM)
0.83
+0.01 (+1.57%)
Which stocks are moving before the opening bell on Friday?
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering...
Which stocks are moving after the closing bell on Thursday?
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of...
Laser Photonics stock is rising higher on Tuesday as LASE investors celebrate a new unit order from L3Harris Technologies.
Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with...